Faculty Associate, Internal Medicine, University of Texas Southwestern Medical Center

Hematology

Barry Mirtsching practices Hematology. He studied medicine at University of Texas Medical School. He has 2 awards "Meaningful Use Stage 1 Certification" and "Super Doctor". Dr. Barry C. Mirtsching is also a published MD. He has 10 publication published. The most recent publication is: A phase II study of weekly nanoparticle albumin-bound paclitaxel with or without trastuzumab in metastatic breast cancer. He accepts all Medicare patients.

Publications

---

• A phase II study of weekly nanoparticle albumin-bound paclitaxel with or without trastuzumab in metastatic breast Cancer.
• Comparison of darbepoetin alfa dosed weekly (QW) vs. extended dosing schedule (EDS) in the treatment of Anemia in patients receiving multicycle chemotherapy in a rando...
• Phase III study comparing gemcitabine plus cetuximab versus gemcitabine in patients with advanced pancreatic adenoCarcinoma: Southwest Oncology Group-directed intergro...
• Neutropenic events in community practices reduced by first and subsequent cycle pegfilgrastim use.
• Multicenter phase II and translational study of cetuximab in metastatic coloRectal carcinoma refractory to irinotecan, oxaliplatin, and fluoropyrimidines.
• Conjunctival involvement with T-cell prolymphocytic Leukemia: report of a case and review of the literature.
• Assessment of hematologic effects and fatigue in Cancer patients with chemotherapy-induced anemia given darbepoetin alfa every two weeks.
• Every-2-week darbepoetin alfa is comparable to rHuEPO in treating chemotherapy-induced anemia. Results of a combined Analysis.
• Adrenal insufficiency and stage D carcinoma of the prostate.

Schools

---

• University Of Texas Medical School At Houston

• Parkland Hospital

• Sw Med School

Conditions Treated

---

• Acute Leukemia
• Adrenal Gland Cancer
• Anal and Rectal Cancer
• Anemia
• View All

Doctors Specialties

---

• Hematology
• Medical Oncology
• Oncology

Accepted Insurances

---

Awards

---

• Meaningful Use Stage 1 Certification
• Super Doctor

Education

---

• University of Texas Medical School

Hospital

---

• Medical City Dallas Hospital
• University of Texas Southwestern Medical Center

Drug Facts

---

NPI NUMBER		1255334496
NPPES Provider LastName		MIRTSCHING
NPPES Provider FirstName		BARRY
NPPES Provider ZIPCode		753907201
NPPES Provider State		TX
Specialty Description		Medical Oncology
Total Claim Count		1084.0
Distinct Opioid Count		2.0
Opioid Claim Count		92.0
Percent Opioid Claims		8.49

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1255334496
Last Name Of The Provider	MIRTSCHING
First Name Of The Provider	BARRY
View All

Similar Doctors

---

	Dr. Gabriel A. Shapiro, MD This Doctor is OpenDoctor Recommended.
	Dr. Nabeel Sarhill, MD This Doctor is OpenDoctor Recommended.
	Dr. Bijal J. Modi, MD This Doctor is OpenDoctor Recommended.
	Dr. Maria I. Juarez, MD
	Dr. Frank E. Lane, MD This Doctor is OpenDoctor Recommended.
	Dr. Yu-Min P. Shen, MD This Doctor is OpenDoctor Recommended.
	Dr. Narotham R. Thudi, MD This Doctor is OpenDoctor Recommended.
	Dr. Craig C. Childs, MD This Doctor is OpenDoctor Recommended.
	Dilipsinh L. Solanki, MB This Doctor is OpenDoctor Recommended.
	Dr. Charles C. Cunningham, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog